These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 9292064)
1. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Dummer W; Bröcker EB; Bastian BC Br J Dermatol; 1997 Aug; 137(2):185-7. PubMed ID: 9292064 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis. Dummer W; Rose C; Bröcker EB Arch Dermatol Res; 1998 Nov; 290(11):598-602. PubMed ID: 9860279 [TBL] [Abstract][Full Text] [Related]
3. In vivo relevance of CD30 in atopic dermatitis. Caproni M; Bianchi B; D'Elios MM; De Carli M; Amedei A; Fabbri P Allergy; 1997 Nov; 52(11):1063-70. PubMed ID: 9404557 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133 [TBL] [Abstract][Full Text] [Related]
5. Soluble cytokine receptor CD30 in atopic disorders: a case-control study. Latza U; Davis S; Wilhelm D; McKnight B; Seyfarth M; Stein H Clin Exp Allergy; 1999 Jan; 29(1):97-104. PubMed ID: 10051708 [TBL] [Abstract][Full Text] [Related]
6. Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis. Fölster-Holst R; Henseler T; Wehde J; Lemke H; Weichenthal M; Christophers E; Hansen HP Acta Derm Venereol; 2002; 82(4):245-8. PubMed ID: 12361126 [TBL] [Abstract][Full Text] [Related]
7. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD30 in pediatric patients with atopic dermatitis. Frezzolini A; Paradisi M; Ruffelli M; Cadoni S; De Pità O Allergy; 1997 Jan; 52(1):106-9. PubMed ID: 9062638 [TBL] [Abstract][Full Text] [Related]
9. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention. Bottari V; Frezzolini A; Ruffelli M; Puddu P; Fontana L; De Pità O Allergy; 1999 May; 54(5):507-10. PubMed ID: 10380784 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD30 and CD23 in cord blood are not related to atopy in early childhood. Oymar K; Laerdal A; Bjerknes R Pediatr Allergy Immunol; 2000 Nov; 11(4):220-4. PubMed ID: 11110575 [TBL] [Abstract][Full Text] [Related]
12. Allergen-induced CD30 expression on T cells of atopic asthmatics. Leonard C; Tormey V; Faul J; Burke CM; Poulter LW Clin Exp Allergy; 1997 Jul; 27(7):780-6. PubMed ID: 9249270 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous CD30+ cells in children with atopic dermatitis. Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781 [TBL] [Abstract][Full Text] [Related]
14. Soluble CD30 and cyclosporine in severe atopic dermatitis. Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723 [TBL] [Abstract][Full Text] [Related]
15. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis. Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317 [TBL] [Abstract][Full Text] [Related]
16. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Frezzolini A; Paradisi M; Zaffiro A; Provini A; Cadoni S; Ruffelli M; De Pità O Allergy; 2002 Sep; 57(9):815-20. PubMed ID: 12169178 [TBL] [Abstract][Full Text] [Related]
17. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy. Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865 [TBL] [Abstract][Full Text] [Related]
18. Circulating skin-homing T cells in atopic dermatitis. Selective up-regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy. Piletta PA; Wirth S; Hommel L; Saurat JH; Hauser C Arch Dermatol; 1996 Oct; 132(10):1171-6. PubMed ID: 8859027 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363 [TBL] [Abstract][Full Text] [Related]
20. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Yamamoto J; Adachi Y; Onoue Y; Kanegane H; Miyawaki T; Toyoda M; Seki T; Morohashi M Allergy; 2000 Nov; 55(11):1011-8. PubMed ID: 11097309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]